Line 88: |
Line 88: |
| | | | | |
| |- | | |- |
− | | Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement||Disease|| ||FQR | + | | Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden |
− | | | + | |FQR |
| + | |Complete |
| | | | | |
| | | | | |
| |- | | |- |
− | | Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement||Disease|| ||FQR | + | | Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement||Disease||Daynna J.Wolff |
− | | | + | |FQR |
| + | |PENDING |
| | | | | |
| | | | | |
| |- | | |- |
− | | Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement||Disease|| ||FQR | + | | Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding |
− | | | + | |FQR |
| + | |Complete |
| | | | | |
| | | | | |
| |- | | |- |
− | | Myeloid/Lymphoid Neoplasms with PCM1-JAK2||Disease|| ||FQR | + | | Myeloid/Lymphoid Neoplasms with PCM1-JAK2||Disease||Sarah Rapisardo |
− | | | + | |FQR |
| + | |PENDING |
| | | | | |
| | | | | |